Thursday, June 11, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1197 of 1,261
  1. US 6441019

    Cyclocarbamate and cyclic amide derivatives

    Ligand Pharmaceuticals Incorporated Β· Granted Aug 27, 2002 Β· Expires Aug 22, 2022

    expired
  2. US 6440946

    Multiple-agents-binding compound, production and use thereof

    Takeda Chemical Industries Ltd. Β· Granted Aug 27, 2002 Β· Expires Aug 22, 2022

    expired
  3. US 6440947

    Method for treating occlusive peripheral vascular disease and coronary disease

    The Regents of the University of California Β· Granted Aug 27, 2002 Β· Expires Aug 22, 2022

    expired
  4. US 6436980

    Peptidomimetic efflux pump inhibitors

    Essential Therapeutics, Inc. Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  5. US 6437005

    Active topical skin protectants using polymer coated metal alloys

    The United States of America as represented by the Secretary of the Army Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  6. US 6437116

    VMP-like sequences of pathogenic borrelia

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  7. US 6436989

    Prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  8. US 6436629

    Modulating angiogenesis

    The Regents of the University of California Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  9. US 6436667

    Human NKX-6.1 polypeptide-encoding nucleotide sequences

    The Regents of the University of California Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  10. US 6436919

    Local anesthetic compounds

    Theravance, Inc. Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  11. US 6436906

    9-amino-14-membered macrolides derived from leucomycins

    Enanta Pharmaceuticals, Inc. Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  12. US 6436929

    Cyclothiocarbamate derivatives as progesterone receptor modulators

    Ligand Pharmaceuticals Incorporated Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  13. US 6436966

    Adenosine A3 receptor antagonists

    Takeda Chemical Ind., Ltd. Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  14. US 6437128

    Cribrostatins 3-5

    THE ARIZONA BOARD OF REGENTS Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  15. US 6436700

    Anti-sense p21 k-ras

    The Board of Regents of the University of Texas System Β· Granted Aug 20, 2002 Β· Expires Aug 15, 2022

    expired
  16. US 6432434

    Treatment of and/or prophylaxis against brain and spinal cord injury

    The United States of America as represented by the Secretary of the Army Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  17. US 6433137

    TUP1 sequences from Candida albicans and methods for screening agents for inhibiting virulence in Candida albicans using TUP1

    The Regents of the University of California Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  18. US 6432996

    Pharmaceutical composition

    Takeda Chemical Industries Ltd. Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  19. US 6432395

    Cleaning composition containing naturally-derived components

    Cogent Environmental Solutions Ltd. Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  20. US 6433136

    Cell density signal protein suitable for treatment of connective tissue injuries and defects

    The Regents of the University of California Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  21. US 6433023

    Compositions having anti-leishmanial activity

    The United States of America as represented by the Secretary of the Army Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  22. US 6432918

    Methods and compositions for optimization of oxygen transport by cell-free systems

    The Regents of the University of California Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  23. US 6433037

    Method of preparing molding compositions with fiber reinforcement and products obtained therefrom

    Reinforced Polymers, Inc. Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired
  24. US 6432667

    Polynucleotide encoding TIE-2 ligand-4

    REGENERON PHARMACEUTICALS, INC. Β· Granted Aug 13, 2002 Β· Expires Aug 8, 2022

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.